tiragolumab,etoposide,atezolizumab,carboplatin
roche
['skyscraper 02', 'lung', 'atezo', 'improve ', 'tiragolumab']
#asco2022 #smallcell
skyscraper 02 - atezo+carboplatin+etoposide +/- tiragolumab in extensive stage small cell lung cancer. failed to improve os /pfs
disappointed results of anti-tigit. is it time to include small cell molecular subtypes into trials?
Heme Onc Chief Fellow @ University of New Mexico/ Thoracic and Head and Neck Oncology /Latino ????????